Royalty Pharma
RPRX
#628
Rank
โ‚น3.637 T
Marketcap
โ‚น6,326
Share price
-1.24%
Change (1 day)
81.04%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): โ‚น141.94

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is โ‚น142.65. In 2025 the company made an earnings per share (EPS) of โ‚น166.90 a decrease over its 2024 EPS that were of โ‚น179.66.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น141.94-14.95%
2025โ‚น166.90-7.1%
2024โ‚น179.66
2020โ‚น141.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
โ‚น252.22 76.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,881 1,920.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น483.19 238.73%๐Ÿ‡บ๐Ÿ‡ธ USA